1 December 2021
Marechale Capital plc
("Marechale Capital" or the "Company")
Half-yearly Results
Marechale Capital plc today announces its unaudited half-yearly results for
the six months ended 31 October 2021.
Chairman’s Statement
I am delighted to report significant progress at Marechale Capital which
continues to build on the success we reported in our 2020/21 final results
published in August.
Financial and Operational highlights are as follows;
* Reported NAV/share increases to 2.7p
* Gross Profit up 75%
* Profit before tax rises to £1.5m
* Investment and financing round in Weardale Lithium completed
* Luke Johnson acquires a significant shareholding
During the six months we generated a Gross Profit of £227,500 (2020:
£130,000) and delivered a small Operating loss of £15,000 (2020: Operating
loss £64,000). However, the gains on investments have resulted in a Profit
before tax of £1,501,000 (compared to a Loss before tax in 2020 of £64,000).
The investment gains, which are unrealised, are primarily due to the £1.5m
uplift on our investment in Weardale Lithium Ltd in the last six months and a
£320,000 uplift on our investment in Future Biogas Group (in the six months
to April 2021). The Board remains positive about these and the other
investments the Company has made as part of its corporate finance
activities.
Net Assets have increased from £0.99m to £2.24m. At 31 October 2021 we
held cash at bank of £358,000.
The Marechale Capital team remain busy working on new and existing projects in
the hospitality, clean energy and technology sectors.
Mark Warde-Norbury
Chairman
The information communicated in this announcement contains inside information
for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014
For further information please contact:
Marechale Capital Mark Warde-Norbury / Patrick Booth-Clibborn Tel: +44 (0)20 7628 5582
Cairn Financial Advisers LLP Jo Turner / Sandy Jamieson Tel: +44 (0)20 7213 0880
Income Statement (unaudited)
6 months ended 31 October 2021 2020
£
Revenue 497,194 175,837
Cost of sales (269,759) (45,999)
Gross profit 227,435 129,838
HMRC Furlough Income - 30,655
Administrative expenses (242,926) (224,932)
Operating loss (15,491) (64,439)
Investment revenues 1,516,726 -
Profit/ (loss) before tax 1,501,235 (64,439)
Taxation - -
Profit/ (loss) after tax 1,501,235 (64,439)
Profit/ (loss) per share
(Pence) (Pence)
- Basic 1.70 (0.1)
- Diluted 1.65 (0.1)
Balance Sheet (unaudited)
As at 31 October 31 October
2021 2020
Current assets
Available for sale investments 1,982,566 52,039
Trading investments 90,013 881
Trade and other receivables 41,884 28,162
Cash and cash equivalents 357,875 176,675
2,472,338 257,757
Current liabilities
Trade and other payables PAYE Bounce-back Loan (56,950) (10,283) (47,500 (72,343) (36,156) (50,000)
Total current liabilities (114,733) (158,499)
Net assets 2,237,605 99,258
Equity
Capital and reserves attributable to equity shareholders
Share capital Share premium 707,690 181,247 461,449 -
Reserve for own shares (50,254) (50,254)
Retained profits/ (losses) 1,465,594 (345,965)
Reserve for share based payments 53,328 34,028
2,357,605 99,258
Cash Flow Statement (unaudited)
6 months ended 31 October 31 October
2021 2020
£ £
Net cash from operating activities
Profit/ (loss) after tax 1,501,235 (64,439)
Provision for share based payments Reverse unrealised gains on investments Reverse interest paid 10,619 (1,517,036) 310 5,075
Operating cash flows before movements in working capital (4,872) (59,364)
Movement in working capital
Decrease in receivables 8,713 33,827
Increase/ (decrease) in payables 6,018 (5,020)
14,731 28,807
Operating cash flow 9,859 (30,557)
Investment activities
Expenditure on available for sale investments (42,462) -
Cash flow from investing activities (42,462) -
Financing Share Capital Bounce-back Loan Interest paid Net financing 160,000 (2,500) (310) 157,190 - 50,000 - 50,000
Net (decrease)/ increase in cash and cash equivalents 124,587 19,443
Cash and cash equivalents at start of the period 233,287 157,232
Cash and cash equivalents at end of the period 357,874 176,675
Increase in cash and cash equivalents 124,587 19,443
This financial information has been prepared in accordance with IFRS and
International Financial Reporting Interpretations Committee ('IFRIC')
interpretations adopted by the European Union, and with those parts of the
Companies Act 2006 applicable to companies reporting under IFRS, with the
prior period being reported on the same basis.
Copyright (c) 2021 PR Newswire Association,LLC. All Rights Reserved